Enhancement of free fatty acid incorporation into phospholipids by choline plus cytidine

Brain Res. 1999 Mar 20;822(1-2):52-9. doi: 10.1016/s0006-8993(99)01072-0.

Abstract

Cytidine and choline, present in cytidine 5'-diphosphate choline (CDP-choline), are major precursors of the phosphatidylcholine found in cell membranes and important regulatory elements in phosphatide biosynthesis. Administration of CDP-choline to rats increases blood and brain cytidine and choline levels; this enhances the production of endogenous CDP-choline which then combines with fatty acids (as diacylglycerol), to yield phosphatidylcholine. We examined the effect of providing cytidine and choline on incorporation of free fatty acids into phosphatidylcholine and other major phospholipids in PC12 cells. Addition of equimolar cytidine and choline (100-500 microM) to [3H]-arachidonic acid (50 microM, 0.2 microCi, bound to bovine serum albumin) dose-dependently increased the accumulations of [3H]-phosphatidylcholine (PtdCho), [3H]-phosphatidylinositol (PtdIno) and [3H]-phosphatidylethanolamine (PtdEtn) (by up to 27+/-3%, 16+/-3% and 11+/-3%, respectively, means+/-S.E.M.). This effect was seen with 8-18 h of incubation. The incorporation of [3H]-oleic acid into [3H]-PtdCho was even more enhanced (by up to 42+/-3%) as were the incorporations of [14C]-choline and [3H]-glycerol. The effects of choline and cytidine were enhanced by 12-O-tetradecanoylphorbol-13-acetate (TPA, 1 microM), which activates CTP:phosphocholine cytidylyltransferase (CT) and facilitates choline uptake. Replacing choline by ethanolamine also enhanced the incorporation of [3H]-arachidonic acid into [3H]-PtdEtn, [3H]-PtdIno and [3H]-PtdCho. Arachidonic acid (10-200 microM) alone failed to affect the incorporation of [14C]-choline into phosphatidylcholine. We suggest that the increases in phospholipid synthesis caused by concurrent cytidine and choline supplementation enhance the incorporation of arachidonic acid and certain other fatty acids into the major glycerophospholipids. Removing these fatty acids as source of potentially toxic oxidation products could contribute to the beneficial effects of CDP-choline in treating stroke or other brain damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism
  • Arachidonic Acid / pharmacology
  • Carbon Radioisotopes
  • Carcinogens / pharmacology
  • Choline / pharmacology*
  • Choline-Phosphate Cytidylyltransferase / metabolism
  • Cytidine / pharmacology*
  • Cytidine Triphosphate / analogs & derivatives
  • Cytidine Triphosphate / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Ethanolamine / pharmacology
  • Fatty Acids, Nonesterified / metabolism*
  • Glycerol / metabolism
  • Glycerol / pharmacology
  • Neurons / drug effects
  • Neurons / enzymology*
  • PC12 Cells
  • Phospholipids / metabolism*
  • Phosphorylation
  • Rats
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tritium

Substances

  • Carbon Radioisotopes
  • Carcinogens
  • Enzyme Inhibitors
  • Fatty Acids, Nonesterified
  • Phospholipids
  • Tritium
  • cyclopentenylcytosine 6-triphosphate
  • Arachidonic Acid
  • Cytidine
  • Ethanolamine
  • Cytidine Triphosphate
  • Choline-Phosphate Cytidylyltransferase
  • Choline
  • Tetradecanoylphorbol Acetate
  • Glycerol